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Introduction
Exposure of neutrophils (PMN) to chemoattractants in vitro or in vivo causes marked increases in the surface expression of several membrane-associated proteins by inducing rapid translocation of preformed intracellular storage pools to the PMN surface (1, 2) . These include the C3b receptor (CR1),1 the 1. Abbreviations used in this paper: CR1 and CR3, C3b and C3bi receptors; PIPLC, phosphatidyl inositol-specific phospholipase C; R, receptor.
C3bi receptor (CR3), receptors for chemoattractant peptides, decay accelerating factor, and the cytochrome of the NADPH oxidase complex (1) (2) (3) (4) (5) . In contrast, surface expression of Fcy receptors (R) is relatively stable after stimulation of PMN with chemoattractants and other stimuli that have been shown to induce six-to eightfold increases in surface expression of other membrane proteins ( 1, 2, 6) .
Two recently published observations caused us to reevaluate the effects of chemoattractant stimulation of PMN on expression and movement of Fcy R III in these cells. First, Turner et al. (7) found that the Fcy R III on the PMN surface constituted less than one-half of the total cellular content of this receptor and, thus, that PMN contained a substantial intracellular pool ofFcy R III. This was confirmed by Jost et al. (8) , who demonstrated intracellular Fcy R III in PMN by immunoelectron microscopy. Second, Huizinga et al. (9) showed that activation of PMN with FMLP caused shedding of Fcy R III from the cell surface. Thus, we proposed that the relative stability ofFcoy R III on the surface of PMN during chemoattractant stimulation represented translocation ofintracellular Fcy R III to the PMN surface that roughly matched the loss of surface Fcoy R III receptors caused by shedding. We reasoned that, if most of the surface Fcy R III on the surface of resting PMN could be removed before FMLP stimulation, then the appearance of new Fcy R III on the cell surface would be more readily detectable. Tosi and Berger ( 10) recently documented that Fcy R III on PMN is sensitive to cleavage by elastase. Because Fcy R III on PMN is anchored in the plasma membrane by a glycolipid anchor, it can also be cleaved by phosphatidyl inositolspecific phospholipase C (PIPLC) (9) . By first using elastase or PIPLC to cleave 85-90% of the Fcy R III from the surface of resting PMN, we were able to observe large increases in surface expression of Fc'y R III upon stimulation ofPMN with FMLP, with concomitant depletion of intracellular Fcy R III. Additional studies comparing the time course and dose response of FMLP-induced shedding ofFcy R III with those for its translocation provided further insight about the regulation of surface expression of Fcy R III during chemoattractant stimulation of these cells.
Methods
Reagents. Neutrophil elastase (875 U/mg) was purchased from Elastin Products, Pacific, MO. FMLP, ionomycin, PMSF and cycloheximide were purchased from Sigma Chemical Co., St. Louis, MO. Monoclonal antibody against Fcy R III (CD16) from hybridoma clone 3G8 was kindly provided by Dr. Jay Unkeless, Mount Sinai Medical Center, New York. Monoclonal antibody against Fcy R II (CD32) was the gift Purification and preparation of neutrophils. PMN were purified from the peripheral blood ofhealthy adults by sedimentation with dextran and centrifugation of the resulting leukocyte-rich plasma over a Ficoll-Hypaque cushion as previously described ( 11) , followed by hypotonic lysis of residual red blood cells. The purity and viability of these PMN preparations were consistently > 95%. For experiments that required removal ofFc-y R III from the PMN surface before stimulation, the cells were incubated at 370C for 30 min with 30 Mg/ml of neutrophil elastase or for 60 min with 0.1 U/ml PIPLC. After washing to remove the enzyme, treated or control PMN were incubated with a range of agents including FMLP, ionomycin, EDTA, EGTA, and/or cycloheximide for durations up to 120 min. PMN supernatants were treated with I mM PMSF immediately after recovery and then stored on ice until assayed for released Fcy R III.
Analysis ofsurface Fcy R III expression by immunofluorescence flow cytometry. After various treatments, PMN (I x 106) were incubated for 30 min at 4VC with an excess ofmonoclonal antibody (3G8) against Fcy R III, or an irrelevant isotype-matched control antibody. Cells were washed three times in Dulbecco's PBS (Gibco Laboratories, Grand Island, NY) and then incubated with FITC-conjugated goat F(ab')2 anti-mouse IgG (Cappel Laboratories, West Chester, PA) for an additional 30 min at 4VC. After further washing and resuspension in PBS, cells were analyzed in a FACS Analyzer (Becton, Dickinson & Co., Mountain View, CA), and the mean fluorescence of 5,000 cells was used as a measurement ofsurface expression ofFcy R III, as previously described (10) .
Preparation offixed, permeabilized PMNfor immunofluorescent staining. Fixation and permeabilization of PMN for direct fluorescent staining of intracellular Fcy R III was accomplished by using a modification of a method previously described (7) . Briefly, PMN recovered after various treatments were first fixed for 2 h with cold 2% paraformaldehyde. Aliquots of these fixed PMN were then permeabilized by suspending them in 0.1% ovalbumin/PBS/0.1 M glycine with 0.04% saponin for all remaining steps in indirect immunofluorescent staining, including 30-min incubation at room temperature with the anti-Fcy R III MAb 3G8 or a mouse IgGl control MAb, and staining with a FITCconjugated F(ab')2 goat anti-mouse IgG second antibody. After three additional washes by centrifugation in the ovalbumin/PBS/saponin, cells were washed once and resuspended in PBS before flow cytometric analysis and fluorescence microscopy. Parallel aliquots of fixed PMN were treated identically but without saponin for non-permeabilized controls.
Cavitation and subcellularfractionation ofPMN. PMN were subjected to nitrogen cavitation and discontinuous Percoll density gradient fractionation as described by Borregaard and Tauber ( 12) . Nuclei and unbroken cells were removed from the crude PMN cavitate by centrifugation at 500 g for 10 min at 4°C. In 15-ml polycarbonate centrifuge tubes, 5 ml of Percoll, 1.12 g/ml, was layered under 5 ml of Percoll, 1.050 g/ml; 3 ml of PMN cavitate was then layered on top of the Percoll gradient and centrifuged for 15 min at 48,000 g. Fractions ( 1.0-1.2 ml) were collected from the bottom ofthe gradient into polypropylene tubes that contained 10 ,l of 100 mM PMSF and held on ice until analyzed.
Microtiter plate assays of markers for granule and plasma membranefractions. Alkaline phosphatase in density gradient fractions was assayed by mixing aliquots (50 Ml) of each fraction with 50 MI of a solution ofp-nitrophenyl phosphate ( 1 mg/ml; Sigma Chemical Co.) in wells of a 96-well microtiter plate. After 60 min at room temperature, the absorbance at 410 nm was read in an automated microtiter plate reader (Dynatech Laboratories, Inc., Alexandria, VA). After correction for turbidity in some fractions, peak alkaline phosphatase activity was used to identify plasma membrane-containing fractions ( 12) .
Lactoferrin in density gradient fractions was measured using a sandwich ELISA as previously described ( 13) , and peak lactoferrin values were used to identify secondary (specific) granule-containing fractions.
A modification of the method described by Henson Western blot analysis ofFcy R III in PMNfractions and supernatants of stimulated PMN using MAb 3G8. PMN fractions from the density gradients or activated PMN supernatants described above were subjected to SDS-PAGE by the method of Laemmli (15) , using 10% acrylamide gels under non-reducing conditions. An aliquot of a PMN lysate that had been prepared previously with 0.05% NP-40 and I mM PMSF and stored at -80'C was used as a positive blotting control for Fcy R III. Identically prepared lysates of an airway epithelial cell line, 9HTEo (kindly provided by Dieter Gruenert, San Francisco, CA) was used as a negative cell control. Electrotransfer ofproteins from the gels to nitrocellulose paper was achieved using a Transphor electrophoresis unit, as previously described (Hoefer Scientific Instruments, Inc., San Francisco, CA) (16 40 ,g/ml in 1% BSA/PBS and incubated for 1 h on a rocker platform at 4°C. Lanes were then washed three times for 20 min each with PBS/1% BSA/0.1% Tween 20. Goat anti-mouse IgG F(ab')2 conjugated to alkaline phosphatase (Southern Biotech, Birmingham, AL) was diluted 1:500 in 1% BSA and laid over each lane. After incubation for 1 h, as above, the nitrocellulose paper was again washed three times with PBS/BSA/Tween, removed from the Decaprobe unit, rinsed in PBS, and immersed at room temperature in a coupled substrate solution containing nitroblue tetrazolium and 5-bromo-4-chloro-3-indolyl phosphate. The substrate reaction was stopped by rinsing several times in distilled water. The development of a broad band on the nitrocellulose paper in the appropriate molecular mass range (50-70 kD) was taken to indicate the presence and relative amount of Fcy R III in a given sample.
Biotinylation ofPMN surface proteins. Suspensions of PMN ( 1.0-1.5 X 108 cells) were incubated with 0.5 mg/ml sulfo-N-hydroxy-succinimidobiotin (Pierce Chemical Co., Rockford, IL) in PBS at pH 8.0 for 1 h at 4°C ( 17) . Cells were then washed three times in PBS, pH 7.4. Surface biotinylation was confirmed by incubating aliquots of labeled and unlabeled cells with a streptavidin-FITC conjugate, then analyzing cells by fluorescence flow cytometry. These surface-biotinylated cells were used to prepare PMN subcellular fractions, as above. Removal of surface-biotinylated proteins from PMN gradient fractions was accomplished by repeated adsorption with excess avidin coupled to agarose beads (Pierce Chemical Co.). Streptavidin blots to detect biotinylated proteins were performed identically to the 3G8 MAb blots described above, except that a 1:5,000 dilution of streptavidin-alkaline phosphatase (Sigma Chemical Co.) was used instead of the antibodies. , and also confirmed that surface Fc-y R III accounted for less than half of the total cellular content of this receptor in resting PMN (see Fig. 8 ). The mean fluorescent intensity of 5,000 cells from each of the six PMN suspensions represented in Fig. 3 (top) was determined by flow cytometry, and the Fcy R III-specific intracellular fluorescence value for the 370C PMN and the FMLP-treated PMN were expressed as a percentage of that for the 0°PMN. As shown in Fig. 3 the Fcy R III detected in fraction 8 (alkaline phosphatase or "plasma membrane" peak) might represent an additional intracellular pool of Fcy R III that comigrated in the density gradient with the plasma membrane. This was further investigated as described below. . . ' . S . . = . ; ' $ . i . _ _ were disrupted by nitrogen cavitation, and membrane fractions were separated on a discontinuous Percoll gradient, as described. Markers for primary or azurophilic granules ( 1; myeloperoxidase), secondary or specific granules (2; lactoferrin) and plasma membrane (P; alkaline phosphatase) were assayed as described. As shown in A, three distinct membrane populations were delineated based on marker peaks in the gradient fractions. In B, western blots for Fcy R III in Part ofthe Fcy R III in the "plasma membrane-containing fraction" ofPMN cavitates represents additional intracellular Fc~y R III. To address the possibility that some of the intracellular Fcy R III comigrates with plasma membrane in density gradients, as proposed, we surface-labeled PMN with biotin in the cold, and prepared N2 cavitate of PMN, as before. Half of the cavitate was repeatedly adsorbed with solid-phase avidin to remove biotinylated (cell surface) proteins. Density-gradient fractions of both the non-avidin-treated and the avidin-adsorbed cavitates were assessed by Western blot for Fcy R III. Fraction 8 was confirmed for both cavitates as having the largest content of Fcy R III, as well as the alkaline phosphatase peak, as in the previous experiments. When fraction 8 from each condition was subjected to SDS-PAGE and blotted with streptavidin-alkaline phosphatase, it was evident as shown in Fig. 6 , that virtually all of the biotinylated (cell surface) proteins had been removed by avidin adsorption (lane a vs. lane b, respectively). In contrast, the Western blots for Fcy R III in fraction 8 from the non-avidin-treated vs. the avidin-adsorbed cavitates (lanes c and d, respectively) demonstrate that a substantial portion of the Fcy R III still remained after adsorption by the solid-phase avidin. Thus, some of the Fcy R III that sedimented with the plasma membrane (fraction 8) in the density gradients had actually been intracellular (thus not biotinylated), in that it was still present after virtually all biotinylated (cell surface) proteins had been removed. Taken together with fraction was treated repeatedly with excess avidin coupled to agarose beads to remove biotinylated surface proteins. Blots of this fraction before and after avidin treatment were performed with a streptavidin-alkaline phosphatase conjugate to confirm the removal of all biotinylated (surface) proteins (lanes a and b, respectively). These were compared with 3G8 Western blots of the same fraction before and after avidin treatment (lanes c and d, respectively), to determine the extent of removal of Fcy R III. Although virtually all of the surface biotinylated proteins were removed by the avidin treatment, a substantial proportion of the Fcy R III remained in this fraction, suggesting that it was intracellular (nonbiotinylated) Fcy R III. 466 stimulated PMN, we next measured shedding at different FMLP concentrations and durations ofexposure. As measured by the 3G8 binding inhibition assay ofPMN supernatants (Fig.  7, bottom) , the amount of Fcy R III released from FMLPstimulated PMN was directly related to the concentrations of FMLP and the duration of exposure to this agent. There was some spontaneous shedding at 370C in the absence of FMLP, which may correspond to the modest gradual decrease in surface Fcy R III at 370C seen for control PMN in Fig. 1 . The very low shedding at 0C here is consistent with data (not shown) indicating steady levels ofsurface Fcy R III at 00C. Near-maximal FMLP-induced shedding occurred by 60 min, but 45-50% of this shedding had already occurred by 15 min. In Fig. 7 (top), parallel measurements of the Fcy R III in these PMN supernatants assayed by 3G8 Western blots gave qualitatively similar results, confirming the time-and concentration-dependent effect of FMLP on Fc'y R III shedding from PMN.
Stoichiometric analysis ofFMLP-induced changes in PMN surface and intracellular Fcy R III. To further examine the relationship between translocation and shedding of Fcy R III and their respective effects on surface expression of this receptor on chemoattractant-stimulated PMN, we performed experiments similar to those described in Fig. 3 . In these studies, however, we assessed concurrent quantitative changes in both surface and intracellular Fcy R III over time by using immunofluorescence flow cytometry with FMLP-treated PMN that had been pretreated with or without elastase, as for Fig. 1 . Specific 3G8 staining of permeabilized PMN was used as a measurement oftotal Fcy R III, while parallel staining ofnonpermeabilized PMN from the same treatment condition was used to measure surface Fcy R III. The difference between the two values was taken as the value for intracellular Fcy R III. As shown in the left panel of Fig. 8 A, there was marked depletion of intracellular Fcy R III after 15 min of FMLP treatment, similar to that shown in Fig. 3 . The overall loss oftotal cellular Fcy R III is consistent with more qualitative assessments ofthe shedding of this receptor from the cell surface, as described earlier in Fig. 7 and as demonstrated in the 3G8 blots of supernatants ofidentically treated PMN depicted in the left panel of Fig. 8 B. The stability of surface levels of Fc-y R III can be accounted for by concomitant translocation from intracellular stores. Identical experiments with PMN whose surface Fcy R III had been removed by pretreatment with elastase (right panel Fig. 8 A) demonstrated the replacement ofsurface Fcy R III by translocation to the cell surface and that the concomitant depletion ofintracellular Fcy R III by FMLP treatment was the same as for non-elastase-treated PMN. There was less FMLPinduced loss oftotal cellular Fcey R III from elastase-pretreated PMN than from control PMN, consistent with the diminished shedding from elastase-treated PMN shown qualitatively in the 3G8 blots of cell supernatants in Fig. 8 B. This decrease in the amount of Fcy R III shed from the elastase-treated cells is presumably because there was very little surface Fcy R III available for shedding at t = 0 min. Thus it is apparent from this more comprehensive assessment that FMLP-induced translocation and shedding of Fcy R III by normal PMN are concurrent processes that exert opposing effects ofcomparable magnitude on the surface expression of this PMN receptor.
Discussion
Neutrophil surface receptors known to be important in phagocytic host defenses and inflammation include the complement receptors, CR1 and CR3, and IgG Fc receptors, especially Fcy R II and Fcy R III (20) (21) (22) (23) . Functional a] acteristics of complement and Fc receptor reviewed elsewhere (9) (10) (11) (12) (13) (24) (25) (26) (27) (28) . Earlie CR3 on PMN showed that FMLP treatn eightfold increases in the expression of ti cell surface, an effect that arms these cell plement-mediated phagocytosis (1, 2 (Fig. 5) . The former includes plasma membrane, but also a substantial nd biochemical charcomponent of alkaline phosphatase-containing membrane rs on PMN have been that is intracellular but which sediments at a density very close r studies of CR1 and to that of plasma membranes ( 18, 19) . Our studies with surnent induced five-to face-biotinylated PMN showed that, while a sizable portion of hese receptors on the the Fcy R III in the alkaline phosphatase peak fractions must Is for enhanced combe from the plasma membrane, some of this Fcy R III was However, previously present at intracellular sites. It may be pertinent that the latent it data, indicated that alkaline phosphatase-containing vesicles described by Borrechemoattractants on gaard et al. ( 18, 19) , the vesicular intracellular storage sites for s (2, 6 Further studies are necessary to define more precisely the nature of these intracellular compartment(s) and to determine the significance of their heterogeneity. Ligand-independent internalization of Fcy R III, as has been described for CR1 (7), either is not induced by FMLP or is otherwise of very small magnitude in comparison to translocation or shedding. This conclusion is based largely on our inability to detect FMLP-induced internalization of surfacebound biotinylated monovalent Fab of 3G8 (Tosi, unpublished data) .
Comparisons of various aspects of shedding vs. translocation indicated that (a) translocation was maximal at 10 nM FMLP, whereas shedding continued to increase with higher FMLP concentrations, up to 1 ,uM, the highest concentration tested; (b) translocation was virtually complete by 15 min, whereas shedding continued for at least 60 min; (c) 5 mM EDTA did not affect translocation, although it has been shown to inhibit shedding (Tosi, unpublished data; 30) ; and (d) the release of Fcy R III from FMLP-treated PMN is greatly reduced, especially at earlier time points, if surface Fcy R III is first removed by elastase and PIPLC, even though translocation is unchanged (Fig. 8 B) . These findings indicated that translocation and release of Fcy R III may occur concomitantly in FMLP-treated PMN but are separately regulated processes. Taken together with studies of PMN cytoplasts by Huizinga et al. (30) , these comparisons also provide strong evidence that cell surface Fcy R III is the source of any Fcy R III released upon FMLP stimulation, that direct secretion of unanchored intracellular Fcy R III is an unlikely alternative mechanism, and that Fcy R III newly translocated to the PMN surface is itself subject to the shedding process.
Although the function ofFcy R III on the PMN surface is at least partly understood (10, (22) (23) (24) (25) (Tosi, unpublished data) . Thus, the potential interactions of shed Fcy R III with IgG remain to be fully characterized.
Our studies show that the effects of FMLP on the movement ofFcy R III in PMN are complex, and involve the stimulation of rapid translocation of one or more preformed intracellular membrane storage pools of Fcy R III to the PMN surface with the concomitant shedding of surface Fc-y R III into the extracellular milieu. The simultaneous translocation and shedding of Fcy R III, while regulated by distinct mechanisms, together serve to maintain the surface expression ofFcy R III at relatively constant levels, during chemoattractant stimulation of PMN, at least until intracellular Fcy R III is depleted. Further studies aimed at more precisely defining its intracellular storage compartments, the molecular mechanisms of its translocation and shedding, and biologic functions of both cell-surface and released Fcy R III will advance the effort to understand more fully the role ofthis PMN receptor in infectious and inflammatory diseases.
